Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Malaysia Receives EMA Approval for New Drug Product Fill Finish Unit for Insulins’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.